Performance Evaluation of Tourism and Hospitality Companies in the Indian Stock Market, A Post-Covid-19 perspective

The Covid-19 pandemic affected the tourism industry's supply chain and reflected its performance and financial market. This paper aims to evaluate the performance of selected tourism-related companies listed in the Indian stock market. This study evaluates the performance of companies share prices and their business performance in post covid perspective. No studies have been conducted before on the performance evaluation of tourism-related companies listed in the Indian Stock Market from a post covid perspective. Fundamental data analysis for the reports from 2018 to 2022 and the share price charts from 2019 to 2022 was undertaken by twenty-five companies in four categorised sectors: Travel Agencies, hotels and resorts, Airlines, and Amusement parks. This study unveils that companies are underperforming in post covid and at the same time, they performed well in the share market after a negative correction due to covid-19. Airline companies are the most affected and least performed in the stock market by their share price growth. The study result helps investors and people interested in the share market assess the influence of a pandemic situation and to help in decision-making related to investment in the tourism and hospitality industry.

Convalescent Plasma Therapy against COVID-19: An Update on the Changing Facets of the ongoing Pandemic.

The severe respiratory infections in the current pandemic coronavirus disease-19 (COVID-19) have influenced more or less every human life. The first person to get infected with this virus was reported in the capital of Hubei province (Wuhan), China, in late December 2019. Since the disease has been declared a pandemic, research scholars and experts have been manufacturing new vaccines or targeted therapies to curb the spread of SARS-CoV-2. However, only limited options have emerged so far, which yet require complete scientific validation by long-term data collection regarding safety and efficacy. In the wake of the recent emerging wave of the pandemic viz omicron variant, changing facets of the viral genome and dearth of preventative and therapeutic possibilities for the management of COVID-19, the usage of Convalescent Plasma Therapy (CPT) may be looked at as a potentially viable option of treatment in the existing situation. Earlier, immune plasma has been used with success in the management of H1N1 influenza virus, MERS-CoV, and SARS-CoV-1 epidemics. In the present unpredictable situation created by the COVID-19 pandemic, the CPT is used with a positive outcome amongst many infected individuals in different parts of the world with acceptable efficacy. This article aimed to present an up-to-date evaluation of existing literature on the efficacy of convalescent plasma as a potential therapy, its safety and effectiveness and the challenges in treating COVID-19.

Clinical-Epidemiology of Tension-Type Headache among the Medical and Dental Undergraduates of King Khalid University, Abha, Saudi Arabia.

Introduction (background): Headache is the primary complaint among students. Headaches mostly have multifactorial causes. The degree of headache severity significantly impacts attitudes, behavior, and academic performance. Objectives: Here, we investigate the demographic epidemiology of tension-type headaches (T.T.H.), and determine the clinical presentation and triggers of the tension-type among headache sufferers. Methods (settings, design): An institutional-based cross-sectional study (descriptive) was conducted on the medical and dental undergraduates at King Khalid University, Abha, Saudi Arabia, from 1 July 2021 to 31 December 2021. Data were gathered using a pre-designed questionnaire. A consecutive sampling method was used in a COVID-19-constrained environment. After preliminary screening of the study population, 460 samples were included. An electronic questionnaire was shared with them, and they were requested to respond. Results: More than half of the participants (258, 56.1%) experienced tension-type headaches, while the remaining 202 (43.9%) never felt a headache. Tension-type headaches manifested as heaviness of the head (44, 17.0%), tightness (126, 48.8%), and dull aching pain (66, 25.7%). Conclusions: T.T.H. is a prevalent condition with a significant impingement on academic work, and psychological health. Tension-type headache sufferers are advised to keep daily diaries to determine triggers, and plan for prevention and treatment progression.

COMPARISON OF THE EFFICACY OF ß BLOCKER AND IVABRADINE IN POST COVID-19 ASSOCIATED INAPPROPRIATE SINUS TACHYCARDIA

Introduction: Covid 19 infection is a recent pandemic which has been linked numerous symptoms post recovery from acute illness. Inappropriate sinus tachycardia[IST] is one of the conditions seen in patients recovered from Covid 19 infection. Currently there is no effective treatment for IST. The present study compares the efficacy of Beta blockers and Ivabradine in controlling the heart rate in IST. Methods: A multi centric prospective study was carried out in 48 patients who developed Post COVID IST for a period of six months. The data was collected and analysed using appropriate statistical test for comparision of minimal, mean, and maximum heart rate at zero, three, and six months. RESULTs: The participants were divided into two random groups. Group A received Metoprolol 50 mg once daily and group B received Ivabradine 5 mg twice daily. Both the groups were followed and then their minimal, mean and maximal heart rate was recorded at zero, three and six months. Both the drugs were found to be effective in decreasing the heart rate with a p value of less than 0.05. Ivabradine was found to be superior than metoprolol in controlling mean heart rate over six months duration with a p value of less than 0.01.Ivabradine also had better effect than metoprolol in controlling maximal heart rate at three months with a p value of less than 0.01 and over six months with a p value of less than 0.001. Conclusion: Treatment of post COVID 19 IST with Ivabradine has shown to improve basal as well as mean heart rate and is more effective than Beta blocker for a long term use. It can be used as a better alternative to Beta blocker who developed its side effects or are intolerant to it. [ FROM AUTHOR] Copyright of Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research) is the property of Journal of Cardiovascular Disease Research and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow up.

A 50-years old male presented with quadriplegia and paresthesia and was diagnosed as Guillain-Barré syndrome (GBS). He was found positive for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) six weeks prior to the onset of weakness. GBS disability score was 4. Electrophysiology showed acute inflammatory demyelinating polyradiculopathy. Anti-SARS-CoV-2 IgG was found positive. Immunological tests for Campylobacter jejuni, Zika virus, Hepatitis E virus, Herpes Simplex virus, Haemophilus influanzae and Mycoplasma pneumoniae were negative. Patient received standard dose of intravenous immunoglobulin and after six months had almost complete recovery of muscle power. This case represents possible association of SARS-CoV-2 infection and GBS with good clinical outcome.

Is Re-introducing Major Open and Minimally Invasive Surgery during COVID-19 Safe for Patients and Healthcare Workers? An International, Multi-centre Cohort Study in the Field of Oesophago-gastric Surgery.

INTRODUCTION: The COVID-19 pandemic has resulted in unparalleled changes to patient care, including the suspension of cancer surgery. Concerns regarding COVID-19-related risks to patients and healthcare workers with the re-introduction of major complex minimally invasive and open surgery have been raised. This study examines the COVID-19 related risks to patients and healthcare workers following the re-introduction of major oesophago-gastric (EG) surgery. PATIENTS AND METHODS: This was an international, multi-centre, observational study of consecutive patients treated by open and minimally invasive oesophagectomy and gastrectomy for malignant or benign disease. Patients were recruited from nine European centres serving regions with a high population incidence of COVID-19 between 1 May and 1 July 2020. The primary endpoint was 30-day COVID-19-related mortality. All staff involved in the operative care of patients were invited to complete a health-related survey to assess the incidence of COVID-19 in this group. RESULTS: In total, 158 patients were included in the study (71 oesophagectomy, 82 gastrectomy). Overall, 87 patients (57%) underwent MIS (59 oesophagectomy, 28 gastrectomy). A total of 403 staff were eligible for inclusion, of whom 313 (78%) completed the health survey. Approaches to mitigate against the risks of COVID-19 for patients and staff varied amongst centres. No patients developed COVID-19 in the post-operative period. Two healthcare workers developed self-limiting COVID-19. CONCLUSIONS: Precautions to minimise the risk of COVID-19 infection have enabled the safe re-introduction of minimally invasive and open EG surgery for both patients and staff. Further studies are necessary to determine the minimum requirements for mitigations against COVID-19.